William Blair equity research analyst Ryan Daniels was quoted in Fierce Healthcare’s coverage of Evolent Health’s sale of its accountable care organization assets to Privia Health.
“Overall, we view the transaction favorably for both parties,” Daniels wrote in a note to investors that was cited by the publication.
Both Evolent Health and Privia Health are covered by William Blair’s Daniels.


